drugset / Trial / NCT05863130
A Study in Healthy Men to Test How BI 764198 is Processed in the Body
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The main objective of this trial is to investigate the basic pharmacokinetics of BI 764198 and its metabolites, total radioactivity including mass balance, excretion pathways and metabolism following oral administration to healthy male volunteers of a single oral dose of BI 764198 (C-14) in i) a classical hADME approach and ii) a hADME microtracer approach.
Timeline
- Start
- 2023-05-03
- Primary completion
- 2023-11-09
- Completion
- 2023-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 764198 | Unknown | — | Oral |
Indications
No indication recorded.